- ￥3500
- GeneTex
- 美国
- GTX01455-10
- 2025年07月14日
- FACS
- Mouse
- Human
企业认证
相关产品推荐更多 >
![S100 antibody [4C4.9]](https://img1.dxycdn.com/2023/0711/451/6106825198874858761-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE. Protect from light.
- 克隆性：
Monoclonal
- 标记物：
PE-Cy7
- 适应物种：
Human
- 保质期：
12 months from the shipping date of the product.
- 目录编号：
GTX01455-10
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Mouse
- 应用范围：
FACS
- 浓度：
0.05 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
CD19
- 抗体英文名：
CD19 antibody [HIB19] (PE-Cy7)
- 抗体名：
CD19 抗体 [HIB19] (PE-Cy7)
- 规格：
100 test
FACS analysis of human peripheral blood lymphocytes using GTX01455-10 CD19 antibody [HIB19] (PE-Cy7).
Solid lone : primary antibody
Dashed line : isotype control
antibody amount : 0.25 μg (5 μl)
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Le Coz C et al., PLoS One 2013 (PMID:24069401)
Beliakova-Bethell N et al., Cytometry A 2014 (PMID:24115734)
Hauber I et al., PLoS Pathog 2013 (PMID:24086129)
Jordan KR et al., Cancer Immunol Immunother 2013 (PMID:24072401)
Lee DH et al., J Neuroinflammation 2013 (PMID:24107235)
Tazawa H et al., Blood 2013 (PMID:23943651)
Trinschek B et al., PLoS One 2013 (PMID:24155968)
Xu X et al., PLoS One 2013 (PMID:24143230)
Lozza L et al., Eur J Immunol 2014 (PMID:24114554)
de la Morena-Barrio ME et al., Orphanet J Rare Dis 2013 (PMID:24139637)
Abbott RJ et al., J Immunol 2013 (PMID:24146041)
J?ger N et al., Cell 2013 (PMID:24139898)
Jelicic K et al., Nat Immunol 2013 (PMID:24162774)
Brisslert M et al., Immunology 2013 (PMID:23844744)
McWilliams L et al., J Leukoc Biol 2013 (PMID:23901121)
Sridharan A et al., J Virol 2013 (PMID:23966397)
Roselli M et al., Oncoimmunology 2013 (PMID:24353914)
Krishnan S et al., J Infect Dis 2014 (PMID:24185941)
Pozzo F et al., J Hematol Oncol 2013 (PMID:24283248)
Aucher A et al., J Immunol 2013 (PMID:24227773)
Compeer EB et al., J Biol Chem 2014 (PMID:24235148)
Sok D et al., PLoS Pathog 2013 (PMID:24278016)
Weidner CI et al., Sci Rep 2013 (PMID:24284763)
Saghafian-Hedengren S et al., J Virol 2013 (PMID:24089567)
Siracusa MC et al., Immunity 2013 (PMID:24332033)
Koo J et al., Immune Netw 2013 (PMID:24385942)
Degauque N et al., PLoS One 2013 (PMID:24386360)
Renand A et al., PLoS One 2013 (PMID:24386482)
Trifonova RT et al., Am J Reprod Immunol 2014 (PMID:24410939)
Chen Q et al., Proc Natl Acad Sci U S A 2014 (PMID:24474774)
Beckwith KA et al., Leukemia 2014 (PMID:24445867)
Sereti I et al., PLoS Pathog 2014 (PMID:24497828)
Ramon S et al., Eur J Immunol 2014 (PMID:24166736)
Schweingruber N et al., Acta Neuropathol 2014 (PMID:24488308)
Mavropoulos A et al., J Immunol Res 2014 (PMID:24741615)
Huang J et al., PLoS One 2014 (PMID:24516613)
Itoua Ma?ga R et al., Biomed Res Int 2014 (PMID:24689045)
Mirza RE et al., Diabetes 2014 (PMID:24194505)
Yamahara K et al., PLoS One 2014 (PMID:24551087)
H?nniger K et al., PLoS Comput Biol 2014 (PMID:24586131)
Chognard G et al., PLoS One 2014 (PMID:24586521)
Greer AM et al., J Clin Invest 2014 (PMID:24569373)
Dutertre CA et al., PLoS One 2014 (PMID:24587165)
Krummey SM et al., Am J Transplant 2014 (PMID:24730049)
Klco JM et al., Cancer Cell 2014 (PMID:24613412)
Baravalle G et al., J Immunol 2014 (PMID:24610015)
Walkowski S et al., PLoS One 2014 (PMID:24614605)
Glauzy S et al., PLoS One 2014 (PMID:24621606)
Imam S et al., Endocr Relat Cancer 2014 (PMID:24623740)
Nguyen KD et al., Mol Immunol 2014 (PMID:24632292)
Rongvaux A et al., Nat Biotechnol 2014 (PMID:24633240)
Pa?no T et al., PLoS One 2014 (PMID:24658332)
Sennikov SV et al., Mediators Inflamm 2014 (PMID:24782596)
Abramowski P et al., PLoS One 2014 (PMID:24667731)
Mukthavaram R et al., J Control Release 2014 (PMID:24685706)
Cartellieri M et al., PLoS One 2014 (PMID:24699869)
Todd SK et al., Rheumatology (Oxford) 2014 (PMID:24729396)
Breton CS et al., J Hematol Oncol 2014 (PMID:24731302)
Dhodapkar MV et al., Sci Transl Med 2014 (PMID:24739759)
Deng N et al., PLoS One 2014 (PMID:24788814)
Raine T et al., Gut 2015 (PMID:24799394)
Wege AK et al., MAbs 2014 (PMID:24870377)
Wilson EM et al., J Infect Dis 2014 (PMID:24813472)
Gutzeit C et al., J Immunol 2014 (PMID:24829410)
Werner-Klein M et al., PLoS One 2014 (PMID:24830425)
Geffner L et al., PLoS One 2014 (PMID:24836916)
Kyoizumi S et al., J Immunol 2014 (PMID:24835400)
Rossi EA et al., PLoS One 2014 (PMID:24841238)
Graves AJ et al., Cytometry A 2014 (PMID:24866990)
Martin E et al., Nature 2014 (PMID:24870241)
Steinsb? ? et al., Nat Commun 2014 (PMID:24909383)
Suszynska M et al., J Ovarian Res 2014 (PMID:24982693)
Conforti A et al., Stem Cells Dev 2014 (PMID:24937591)
Booth JS et al., Front Immunol 2014 (PMID:24995010)
Krupna-Gaylord MA et al., PLoS One 2014 (PMID:24945497)
Masuda H et al., J Am Heart Assoc 2014 (PMID:24965023)
Jo J et al., PLoS Pathog 2014 (PMID:24967632)
Melchiotti R et al., BMC Med Genet 2014 (PMID:24970562)
Lepore M et al., J Exp Med 2014 (PMID:24935257)
Sandler VM et al., Nature 2014 (PMID:25030167)
Du Q et al., BMC Med Genomics 2014 (PMID:25001852)
Kawasaki N et al., J Immunol 2014 (PMID:25000981)
Zhu D et al., Clin Exp Immunol 2014 (PMID:24611451)
Herrera AF et al., Biol Blood Marrow Transplant 2014 (PMID:25017765)
Lozza L et al., Front Immunol 2014 (PMID:25071784)
Scholzen A et al., PLoS One 2014 (PMID:25050555)
Picchianti Diamanti A et al., Clin Exp Immunol 2014 (PMID:24773026)
Sag D et al., J Clin Invest 2014 (PMID:25061873)
Longman RS et al., J Exp Med 2014 (PMID:25024136)
Wang D et al., Arthritis Rheumatol 2014 (PMID:24756936)
thresholds for antigen receptors and other surface receptors on B cells; also regulates B cell development, activation and differentiation CD19 antibody inhibits B cell activation from anti-immunoglobulin Coreceptor with CD21 Earliest B cell
CD19 ／ CD81 白细胞分化抗原及其功能 CDl9 CDl9分子胞膜外区结构属IgSF，包括2个C2样区，胞质区较长，不同种属间有很高的同源性，含有可发生磷酸化的丝／苏氨酸和酪氨酸残基。CDl9分子分布于除浆细胞外的B细胞谱系发育的各个阶段，也是与B细胞识别、黏附和活化有关的CD分子的结构B细胞的重要标记。 此外CDl9还表达于生发中心的FDC，以及某些急性髓细胞白血病细胞。CDl9是CDl9／CD21／CD81信号复合
Western Blotting with Horseradish Pe
7.5, 100mM NaCl, 0.1% Tween 20). 2.Incubate the blot for 30 minutes at 37℃, 1 hour at room temperature, or overnight at 4℃. INCUBATION WITH HORSERADISH PEROXIDASE CONJUGATED ANTIBODY NOTE: THE INCLUSION OF SODIUM AZIDE IS TO BE AVOIDED IN ALL STEPS
技术资料暂无技术资料 索取技术资料
